Related Experiment Video
Updated: Feb 6, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis
Huan Liu1, Siying Li2, Xiaohui Liu1
1MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systematic Biology, School of Life Sciences , Tsinghua University , Beijing 100084 , China.
Abstract:
SIRT3 is a NAD+-dependent mitochondrial protein deacetylase implicated in the regulation of central metabolism and mitochondrial proteostasis. SIRT3 is downregulated in clear cell renal cell carcinoma (ccRCC), which is the most common form of renal cancer. Although ccRCC is characterized by a typical Warburg-like phenotype, mitochondrial dysfunction and elevated fat deposition, it is unknown whether SIRT3 plays a role in tumorigenesis and the development of this disease. In the present study, we found that SIRT3 overexpression and knockdown had opposing effects on the growth of ccRCC cells, decreasing and increasing the rate of cell proliferation, respectively. SIRT3 overexpression also increased mitochondrial mass in ccRCC cells. Unexpectedly, SIRT3 overexpression increased ROS levels, and sensitized cells to oxidative stress. Metabolomics and quantitative proteomics showed that SIRT3 overexpression alterd cellular metabolism and reversed the Warburg effect in ccRCC cells. Further studies demonstrated that SIRT3 promoted mitochondrial biogenesis by increasing both the expression and deacetylation of TFAM (transcription factor A, mitochondrial). Mutagenesis experiments revealed that acetylation of TFAM at K154 impaired TFAM interaction with mitochondrial DNA, thereby decreasing the activity of the protein and, consequently, mitochondrial biogenesis. Overall, our results suggest that SIRT3 regulates mitochondrial biogenesis and that its downregulation promotes a Warburg phenotype in ccRCC.
Insights
Sirtuin 3 (SIRT3) protein deacetylase activity impacts kidney cancer growth by regulating mitochondrial function. SIRT3 downregulation promotes the Warburg effect in clear cell renal cell carcinoma (ccRCC).
Area of Science:
- Mitochondrial biology
- Cancer metabolism
- Renal cell carcinoma research
Background:
- Sirtuin 3 (SIRT3), a NAD+-dependent mitochondrial deacetylase, is crucial for metabolism and mitochondrial health.
- SIRT3 is downregulated in clear cell renal cell carcinoma (ccRCC), the most common kidney cancer.
- The role of SIRT3 in ccRCC tumorigenesis, despite the cancer's known metabolic and mitochondrial alterations, remains unclear.
Purpose of the Study:
- To investigate the role of SIRT3 in ccRCC tumorigenesis and development.
- To determine SIRT3's impact on ccRCC cell proliferation, mitochondrial mass, and oxidative stress.
- To elucidate the molecular mechanisms by which SIRT3 influences ccRCC metabolism and mitochondrial biogenesis.
Main Methods:
- SIRT3 overexpression and knockdown in ccRCC cell lines.
- Cell proliferation assays, mitochondrial mass quantification, and reactive oxygen species (ROS) level measurements.
- Metabolomics, quantitative proteomics, and TFAM (transcription factor A, mitochondrial) deacetylation and interaction studies.
Main Results:
- SIRT3 overexpression decreased ccRCC cell proliferation and increased mitochondrial mass.
- SIRT3 overexpression elevated ROS levels and sensitized cells to oxidative stress.
- SIRT3 reversed the Warburg effect in ccRCC cells, promoting mitochondrial biogenesis via TFAM deacetylation and enhancing its DNA binding.
Conclusions:
- SIRT3 plays a significant role in regulating mitochondrial biogenesis in ccRCC.
- Downregulation of SIRT3 promotes a Warburg phenotype, contributing to ccRCC development.
- Targeting SIRT3 may offer a therapeutic strategy for ccRCC by restoring mitochondrial function.
Related Concept Videos
Animal Mitochondrial Genetics
Feedback Inhibition
Kidney Structure
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Export of Mitochondrial and Chloroplast Genes
Enzyme Inhibition

